Correlation Between Regeneron Pharmaceuticals and Entia Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Entia Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Entia Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Entia Biosciences, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Entia Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Entia Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Entia Biosciences.

Diversification Opportunities for Regeneron Pharmaceuticals and Entia Biosciences

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Regeneron and Entia is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Entia Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entia Biosciences and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Entia Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entia Biosciences has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Entia Biosciences go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and Entia Biosciences

If you would invest  0.02  in Entia Biosciences on September 5, 2024 and sell it today you would earn a total of  0.00  from holding Entia Biosciences or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Regeneron Pharmaceuticals  vs.  Entia Biosciences

 Performance 
       Timeline  
Regeneron Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Entia Biosciences 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Entia Biosciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile technical and fundamental indicators, Entia Biosciences displayed solid returns over the last few months and may actually be approaching a breakup point.

Regeneron Pharmaceuticals and Entia Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regeneron Pharmaceuticals and Entia Biosciences

The main advantage of trading using opposite Regeneron Pharmaceuticals and Entia Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Entia Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entia Biosciences will offset losses from the drop in Entia Biosciences' long position.
The idea behind Regeneron Pharmaceuticals and Entia Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance